STAT+: Pharmalittle: FDA rule change allows pharmacies to offer abortion pills; Medicare could have saved billions if inflationary rebate law existed
Top of the morning to you, and a fine one it is. Balmy breezes and…
Category: Pharmalot
STAT+: Medicare would have saved $3.7 billion on Part B drugs if inflationary rebates were around in a recent three-year period
If rebates had been required for price hikes on most of the nearly 100 medicines…
STAT+: Pharmalittle: Pharma plans to raise U.S. drug prices in January; U.S. sues AmerisourceBergen over opioid crisis
Good morning, everyone, and welcome to a new year. We hope the holiday respite was…
STAT+: Pharmalittle: FDA approves a Genentech blood-cancer drug; Sean Parker expands his immunotherapy research empire
Good morning, Pharmalittle family! Your loyal scribe Ed Silverman is taking today off, so he…
STAT+: Pharmalittle: Merck pays Chinese biotech $175 million for cancer drugs; who will make a gene therapy for very sick kids?
Good morning everyone! Matthew Herper is here, filling in for Pharmalot, who is taking a…
STAT+: California wants to revoke a CVS mail-order license for illegally filling opioid and ADHD prescriptions
California authorities are seeking to revoke a license held by a CVS Health mail-order pharmacy…
STAT+: Pharmalittle: ICER cuts cost-effective price for Pfizer Covid pill; McDonald’s sets targets to reduce antibiotic use in cattle
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: McDonald’s adds targets for limiting antibiotic use in beef to its menu, but doesn’t say when
After being accused of backtracking on a commitment to reduce its use of medically important…
.jpg)
STAT+: Pharmalittle: Pharma wins changes in bill concerning accelerated approval; pharmacy chains restrict purchases of pediatric pain relievers
Rise and shine, everyone, another busy day is on the way. And we can tell…
STAT+: Pharmalittle: FDA adds Lilly diabetes drugs to shortage list; WTO delays decision on extending Covid IP waiver
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: AbbVie leaves pharma industry trade groups; net drug prices see big drop after inflation
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Amid criticism over unaffordable insulin, Lilly strikes a manufacturing deal to supply Africa
In a bid to widen access to insulin in primarily low-income nations in Africa, Eli…
STAT+: Pharmalittle: U.S. prisons refuse to test and treat hepatitis C patients; HHS urges Supreme Court to reject Pfizer argument on Medicare kickbacks
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
.jpg)
STAT+: Pharmalittle: Lawmakers accuse Pfizer of ‘pure greed’ over Covid vaccine price hike; Takeda to spend $4 billion on experimental pill
Good morning, everyone, and how are you today? We are doing just fine, thank you….
STAT+: Lawmakers tell Pfizer CEO to ‘back off’ on planned price hike for Covid-19 vaccine
A pair of U.S. lawmakers wrote Pfizer chief executive officer Albert Bourla that he should…
STAT+: Pharmalittle: Moderna and Merck vaccine lowers risk of skin cancer relapse; Cambodia halts exports of primates used for drug research
Top of the morning to you, and a fine one it is. Crystal clear blue…
STAT+: Amid fears of superbugs, sales of antibiotics used in food-producing livestock barely declined last year
Amid fears of superbugs, the sale of medically important antibiotics given to food-producing livestock declined…
STAT+: Ongoing problems with a new European clinical trial registry could cause ‘catastrophe’
A coalition of pharmaceutical industry and academic medical research associations based in Germany is calling…
STAT+: Cambodia halts exports of non-human primates, threatening drug discovery efforts
Following the recent indictments of several people allegedly involved in a monkey-smuggling operation, Cambodia has…
STAT+: Pharmalittle: Amgen agrees to pay $27.8 billion for Horizon Therapeutics; Roche pharma head steps down
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: Medicare willing to reevaluate coverage of Alzheimer’s drugs; judge tosses shingles-vaccine lawsuits against Merck
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: Mark Cuban’s drug company goes after employer market; FDA slaps import alert on key Sun Pharma plant
Top of the morning to you, and a fine one it is. The sun is…
STAT+: Mark Cuban teams with a business coalition in bid to lower drug costs for employers
In his latest bid to expand access to lower-cost medicines, Mark Cuban’s Cost Plus Drug…
STAT+: FDA scolds company that raised red flags over impurities in many widely used medicines
Two years after an independent laboratory began pushing the U.S. Food and Drug Administration to…
STAT+: Pharmalittle: Zantac lawsuits tossed over inadequate scientific evidence; Lilly tightens access to diabetes drug used for weight loss
Good morning, everyone, and how are you today? We are doing just fine, thank you….
STAT+: Zantac lawsuits are tossed out as judge lambasts lack of evidence showing links to cancer
Several big drugmakers — Sanofi, GSK, Pfizer and Boehringer Ingelheim — will not have to…
STAT+: The prices of 7 drugs were hiked without proof of new benefits, costing the U.S. $805 million in 2021
During 2021, drugmakers substantially raised prices on seven widely used medicines without any new clinical…
STAT+: France’s drug regulator is under investigation for its handling of a thyroid drug
France’s drug regulator is being investigated for issuing misleading information in connection with a thyroid…
STAT+: U.S. delays backing for patent waivers on Covid-19 therapies and diagnostics
The U.S. government will not support extending a Dec. 17 deadline for waiving intellectual property…
STAT+: Pharmalittle: FDA fast tracks OTC version of Narcan; Express Scripts to keep Humira on its formulary but add biosimilars
Hello, everyone, and how are you today? A steely gray sky is hovering this morning…
STAT+: A year after petition, NIH reviews request to lower cancer drug’s cost by sidestepping patents
One year after being asked to widen access to a pricey cancer treatment by using…
STAT+: Pharmalittle: J&J drops out of bidding for Horizon; FDA takes a harder line on fast-track approvals
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: Private equity moving to buy clinical trials firms; data provider limits media access to drug prices
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Gilead wins a key battle with the CDC over patents for its Truvada HIV pill
Gilead Sciences won a key round in its battle with the U.S. government over allegations…
STAT+: Pharmalittle: Roche Alzheimer’s drug didn’t clear enough amyloid; startup to seek approval of nasal swab version of naloxone
Good morning, Jason Mast here filling in for Ed. There are many types of coffee…
STAT+: Afraid of pharma pushback, a health data broker puts up a barrier to drug pricing information
At a time when many Americans are clamoring for more transparency into prescription drug pricing,…
STAT+: Pharmalittle: Detailed data on Alzheimer’s drug hold up to scrutiny; Horizon in takeover talks with three pharma giants
Rise and shine, everyone. The middle of the week is upon us. Have heart, though….
STAT+: Pharmalittle: PhRMA trade group is losing its edge; Eisai CEO tries to silence critics of Alzheimer’s drug
Hello, everyone, and how are you today? Gray skies are hovering over the Pharmalot campus…
STAT+: ‘Skinny labels’ on biosimilar medicines saved Medicare $1.5 billion over a recent five-year period
A hotly contested provision of a federal law designed to speed copycat drugs to market…
STAT+: Pharmalittle: Second clinical trial death may be linked to Eisai-Biogen Alzheimer’s drug; pharma presses the U.K. over ‘out of control’ levy
Good morning, everyone, and welcome to another working week. We hope the weekend respite —…
STAT+: Pharmalittle: FDA approves first gene therapy for hemophilia B; pharma’s reputation slips in U.S.
Happy Thanksgiving Eve from STAT reporter Andrew Joseph, filling in for the day. A note…
STAT+: Pharmalittle: GSK pulls a key blood-cancer drug off the market; Teva picks a new CEO
Good morning, everyone. Damian Garde here filling in for Ed Silverman in the waning days…
STAT+: Pharmalittle: Type 1 diabetes drug is priced at $194,000; abortion opponents sue FDA over abortion pill approval
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Sales of antibiotics for food-producing animals dropped by nearly half in Europe over the past decade
Amid ongoing concerns over the use of medically important antibiotics given to food-producing livestock and…
STAT+: Pharmalittle: WHO pandemic accord may force pharma to disclose prices; FDA OKs first therapy to delay type 1 diabetes
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: Big PBM keeps AbbVie’s Humira on formulary; Lilly CEO says fake tweet means there’s more to do on insulin costs
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: Lilly CEO concedes Twitter flap over insulin costs shows there’s ‘more work to do’
After a tweet from a fake corporate account last week claimed Eli Lilly would give…
STAT+: Pharmalittle: WHO scientist resigns amid shake-up; FDA considers over-the-counter naloxone
Top of the morning to you. The middle of the week is upon us and,…
STAT+: Walmart agrees to pay $3.1 billion in latest settlement stemming from the opioid crisis
In the latest fallout from the opioid crisis that swept the U.S., Walmart agreed to…
STAT+: Pharmalittle: Walmart to pay $3.1 billion to settle opioid claims; Indian Covid vaccine underwent troubling approval process
Good morning, everyone, and how are you today? We are doing just fine, thank you,…